Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1362 |
| Name of the vaccine | LBVH0101 |
| Microbe | Bacteria |
| Disease name | Haemophilus influenzae type b (Hib) |
| Name of bacteria | Haemophilus influenzae |
| Type of vaccine | Conjugate |
| Nucleic acid content | DNA |
| Age | 49 to 84 days |
| Description of the vaccine | Haemophilus Influenzae type b Tetanus toxoid conjugate vaccine |
| Name of the manufacturer | LG Life Sciences |
| Name of the manufacturing country | Korea, Republic of |
| Year of manufacture | 2008 |
| Clinical Phase status | Clinical - Phase 3 |
| Bacterial strain | Anaerobic gram-negative coccobacillus. |
| Efficacy | NA |
| Vaccine formulation | NA |
| Dosage | Three doses at 2, 4, and 6 months. |
| Mechanism of action | NA |
| Route of administration | NA |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | NA |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Combination doses |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NCT01019772 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |